即將開始 NCT07873619

組織碎解術用於腹膜腫瘤及淋巴結:一項先導研究

卵巢癌前列腺癌不適用I 期II 期III 期IV 期

腹膜癌的處理相當棘手。在早期階段,若無症狀,或僅出現許多疾病共有的常見症狀或不適,並不容易被發現或診斷,往往在確診時已屬晚期,治療選擇有限,壽命亦受到限制。

適應症:Lymph Nodes、Peritoneal Tumour

收案條件

納入條件

  • Age ≥ 18 years old
  • Fit for general anaesthesia
  • Peritoneal tumour (eg. intraperitoneal tumour, retroperitoneal tumour) and/or lymph node
  • Size ≤ 10cm for each peritoneal tumour and lymph node
  • With or without distant metastasis
  • Good performance status
  • Tumour visible and targetable by ultrasound with acceptable acoustic windows
  • Adequate hematologic, hepatic, and renal function

排除條件

  • Refusal to take part in clinical trial
  • Not fit for general anaesthesia
  • Poor general condition with limited life expectancy
  • Uncontrolled coagulopathy
  • Extensive bowel interposition preventing safe targeting, per recent porcine safety data linking mis-targeting to bowel injury

收案條件維持 ClinicalTrials.gov 原始英文登錄資料,實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源:ClinicalTrials.gov,每兩週自動更新,最後同步:2026年11月5日。